Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer | MicrobiomeTrials← Back to trialsNCT00804154
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2009-08-14Est. Completion: 2027-02-07
Enrollment target: 45 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Primary MyelofibrosisPost-essential Thrombocythemia MyelofibrosisPost-polycythemia Vera Myelofibrosis
This is a phase II, open label, prospective, single-arm study evaluating the efficacy and safety of selinexor in patient…
Salt Lake City, United StatesCompleted Aug 16, 2023
Intractable PainPalliative Care
Background:
Cancer-induced bone pain (CIBP) is common in people with cancer. Bone cancer can also lead to anxiety, depr…
Bethesda, United StatesEst. completion Dec 1, 2026
Multiple Myeloma
The main purpose of this study is to learn about the safety of linvoseltamab and to find out what is the best dose of li…
Miami, United StatesEst. completion Mar 30, 2033